110 related articles for article (PubMed ID: 35923310)
21. SARS-CoV-2: analysis of the effects of mutations in non-structural proteins.
Senthilazhagan K; Sakthimani S; Kallanja D; Venkataraman S
Arch Virol; 2023 Jun; 168(7):186. PubMed ID: 37344726
[TBL] [Abstract][Full Text] [Related]
22. Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling.
Jauregui AR; Savalia D; Lowry VK; Farrell CM; Wathelet MG
PLoS One; 2013; 8(4):e62416. PubMed ID: 23658627
[TBL] [Abstract][Full Text] [Related]
23. Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.
Gupta V; Haider S; Verma M; Singhvi N; Ponnusamy K; Malik MZ; Verma H; Kumar R; Sood U; Hira P; Satija S; Singh Y; Lal R
mSystems; 2021 Feb; 6(1):. PubMed ID: 33622851
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An
Chaudhuri A
J Mol Struct; 2021 Nov; 1243():130854. PubMed ID: 34121768
[TBL] [Abstract][Full Text] [Related]
25. Structural characterization of nonstructural protein 1 from SARS-CoV-2.
Semper C; Watanabe N; Savchenko A
iScience; 2021 Jan; 24(1):101903. PubMed ID: 33319167
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.
Nakagawa K; Makino S
Cells; 2021 Feb; 10(2):. PubMed ID: 33540583
[TBL] [Abstract][Full Text] [Related]
27. Distinct mutations and lineages of SARS-CoV-2 virus in the early phase of COVID-19 pandemic and subsequent 1-year global expansion.
Chen Y; Li S; Wu W; Geng S; Mao M
J Med Virol; 2022 May; 94(5):2035-2049. PubMed ID: 35001392
[TBL] [Abstract][Full Text] [Related]
28. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Nsp1 suppresses host but not viral translation through a bipartite mechanism.
Shi M; Wang L; Fontana P; Vora S; Zhang Y; Fu TM; Lieberman J; Wu H
bioRxiv; 2020 Sep; ():. PubMed ID: 32995777
[TBL] [Abstract][Full Text] [Related]
30. The First Geographic Identification by Country of Sustainable Mutations of SARS-COV2 Sequence Samples: Worldwide Natural Selection Trends.
Mahmanzar M; Houseini ST; Rahimian K; Namini AM; Gholamzad A; Tokhanbigli S; Sisakht MM; Farhadi A; Kuehu DL; Deng Y
bioRxiv; 2022 Jul; ():. PubMed ID: 35898341
[TBL] [Abstract][Full Text] [Related]
31. Parsing the role of NSP1 in SARS-CoV-2 infection.
Fisher T; Gluck A; Narayanan K; Kuroda M; Nachshon A; Hsu JC; Halfmann PJ; Yahalom-Ronen Y; Finkel Y; Schwartz M; Weiss S; Tseng CK; Israely T; Paran N; Kawaoka Y; Makino S; Stern-Ginossar N
bioRxiv; 2022 Mar; ():. PubMed ID: 35313595
[TBL] [Abstract][Full Text] [Related]
32. Parsing the role of NSP1 in SARS-CoV-2 infection.
Fisher T; Gluck A; Narayanan K; Kuroda M; Nachshon A; Hsu JC; Halfmann PJ; Yahalom-Ronen Y; Tamir H; Finkel Y; Schwartz M; Weiss S; Tseng CK; Israely T; Paran N; Kawaoka Y; Makino S; Stern-Ginossar N
Cell Rep; 2022 Jun; 39(11):110954. PubMed ID: 35671758
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
Thoms M; Buschauer R; Ameismeier M; Koepke L; Denk T; Hirschenberger M; Kratzat H; Hayn M; Mackens-Kiani T; Cheng J; Straub JH; Stürzel CM; Fröhlich T; Berninghausen O; Becker T; Kirchhoff F; Sparrer KMJ; Beckmann R
Science; 2020 Sep; 369(6508):1249-1255. PubMed ID: 32680882
[TBL] [Abstract][Full Text] [Related]
34. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
35. Suppression of host gene expression by nsp1 proteins of group 2 bat coronaviruses.
Tohya Y; Narayanan K; Kamitani W; Huang C; Lokugamage K; Makino S
J Virol; 2009 May; 83(10):5282-8. PubMed ID: 19264783
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 targets ribosomal RNA biogenesis.
Yerlici VT; Astori A; Kejiou NS; Jordan CA; Khosraviani N; Chan JNY; Hakem R; Raught B; Palazzo AF; Mekhail K
Cell Rep; 2024 Mar; 43(3):113891. PubMed ID: 38427561
[TBL] [Abstract][Full Text] [Related]
37. Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2.
Wang Y; Kirkpatrick J; Lage SZ; Carlomagno T
Structure; 2023 Feb; 31(2):128-137.e5. PubMed ID: 36610391
[TBL] [Abstract][Full Text] [Related]
38. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
[TBL] [Abstract][Full Text] [Related]
39. Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis.
Khetran SR; Mustafa R
JMIR Bioinform Biotechnol; 2023; 4():e43906. PubMed ID: 37485046
[TBL] [Abstract][Full Text] [Related]
40. Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.
Vora SM; Fontana P; Mao T; Leger V; Zhang Y; Fu TM; Lieberman J; Gehrke L; Shi M; Wang L; Iwasaki A; Wu H
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35149555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]